Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Expected to Witness a Sustainable Growth over 2023

New report published by Market Research Report Store (MRRS) which offers insights on the global Epidermal Growth Factor (EGF) (CAS 62253-63-8) market.

Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival.

Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/1874/global-epidermal-factor-egf-cas-3

Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market: Forecast by Type / Application / Region

EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that’s why most skin care maker use EGF to care our skin.

And we only investigate the epidermal growth factor (EGF) cosmetic, take no account of the epidermal growth factor (EGF) for research use.

The classification of Epidermal Growth Factor (EGF) includes liquid and powder. The proportion of liquid in 2016 is about 25%, the proportion of powder in 2016 is about 75%.

The application of Epidermal Growth Factor (EGF) is divided into EGF Cream, EGF Lotion, EGF Mask and others. The most of Epidermal Growth Factor (EGF) is EGF Cream, and the market share of that is about 45% in 2016.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 34% in 2016. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 25% in 2016. And South America in the third largest consumption region with the consumption market share of 10%.

Market competition is intense. Pavay, Radiant, BIO-FD&C, LipoTrue, BIOEFFECT are the leaders of the industry, with high-end customers in the industry.

Over the next five years, LPI(LP Information) projects that Epidermal Growth Factor (EGF) (CAS 62253-63-8) will register a 5.8% CAGR in terms of revenue, reach US$ 140 million by 2023, from US$ 110 million in 2017.

Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market: Key Players
Pavay
Radiant
BIO-FD&C
LipoTrue
BIOEFFECT

Ask for Discount on Research Report and Request Sample Copy of Report@
https://www.marketresearchreportstore.com/reports/1874/global-epidermal-factor-egf-cas-3

Related Information:
United States Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Research Report 2018
Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Research Report 2018
North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Research Report 2018
Asia-Pacific Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Research Report 2018
China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Research Report 2018
EMEA Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Research Report 2018
Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Research Report 2018

About Us:
Market Research Report Store (MRRS) is a professional organization related to market research reports in all directions .To provide customers with a variety of market research reports, MRRS cooperates with a large of famous market report publishers all over the world. Owing to our good service and the professional market reports in the wide range, MRRS enjoys a good reputation in the market. In pace with the development of MRRS, more and more customers and market report publishers choose to cooperate with us. As a specialized platform, MRRS upholds the supremacy of customers and aims to provide customers with better service and richer select.

Contact US :
Sales Director (Market Research Report Store)
E-mail: info@marketresearchreportstore.com
Tel: +86-15521064060 00852-58197708(HK)
Add: 17890 Castleton Street Suite 218 City of Industry CA 91748 United States
Website: https://www.marketresearchreportstore.com

This release was published on openPR.